Appco Pharma LLC recalls
3 recalls filed under Appco Pharma LLC. The most recent was published April 8, 2026.
-
Class II · 7 months ago
Appco Pharma LLC Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle recall: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
-
Class II · 7 months ago
Appco Pharma LLC Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle recall: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
-
Class II · 7 months ago
Appco Pharma LLC Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle recall: cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities
cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin impurity C (NNP) above acceptable limits.
About this page
Appco Pharma LLC appears here because a federal agency named it as the recalling firm or the brand on the label. A recall is not a judgement about everything the company sells — it covers only the lot codes and models listed in each notice.